All News

Officials with the FDA have approved ferric derisomaltose (Monoferric, Pharmacosmos Therapeutics Inc.) injection 100 mg/mL. 

A pharmacy group is taking a wait-and-see approach after California Governor Gavin Newsom (D) announced several drug reforms–including a state generic prescription drug label.

Alkermes is seeking FDA approval for its investigational antipsychotic drug candidate ALKS 3831 for schizophrenia and bipolar I disorder.

Data tracked by wearable fitness sensors may help with real-time surveillance of seasonal respiratory infections, such as influenza.

How the pharmacy team at Novant Health Brunswick Medical Center ensured patients got their medications during Hurricane Florence. 

If approved, dupilumab (Dupixent, Regeneron and Sanofi) would be indicated for use as an add-on maintenance treatment for children ages 6 to 11 years with moderate-to-severe atopic dermatitis.

Ticagrelor (Brilinta, AstraZeneca) reduced the risk of stroke and death when taken with aspirin compared with aspirin alone.

Administration time for warfarin did not affect the stability of the drug’s anticoagulation effect, a new study showed. 

Fidaxomicin (Dificid, Merck) is indicated in adults and pediatric patients aged 6 months and older for the treatment of Clostridioides difficile-associated diarrhea.

The 2019 Novel Coronavirus outbreak in Wuhan City, China has caused concern as 2 cases have been recently reported in the United States.

Evidence-based recommendations focus on immunomodulators, biologics, and small molecules for the management of ulcerative colitis.

Kroger continues to expand on their health care and pharmacy services with the introduction of flu testing and strep throat testing in certain markets.

Pfizer announced the introduction of 3 new oncology biosimilars to the US market at a substantially discounted price.

Patients with chronic pain using medical cannabis reported less nighttime awakenings initially, but tolerance may build with frequent use.

A new CDC report found that benzodiazepines were prescribed at 27 annual physician visits per 100 adults from 2014 to 2016.

Flu vaccine effectiveness data are not available yet, but the latest flu-related death and hospitalization estimates are in.

A preemptive pain management program involving OTC medications can help reduce the need for opioid prescriptions following certain surgeries.

Older adults with diabetes are experiencing declines in all-cause mortality rates, whereas younger adults continue to be affected more by the condition.

Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.

Quality, speed, and price has been referred to as the "Unattainable Triangle".

FDA approval decision expected in the second quarter of 2020.

Proton pump inhibitors (PPIs) may be linked to concentration and memory problems in individuals with a history of breast cancer.

As we head into a new year, Drug Topics® is exploring some of the latest pharmacy trends and how they will shape the industry in the next decade. 

Solriamfetol (Sunosi, Jazz Pharmaceuticals) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea was approved on March 20, 2019.

The FDA has approved semaglutide (Ozempic, Novo Nordisk) for the reduction of major adverse cardiovascular (CV) events in patients with type 2 diabetes and established CV disease.

Let’s take a look at some of the most common issues pharmacists are facing, as seen recently on Facebook.

Pharmacists can play an integral role in managing patients with psoriasis through medication therapies and lifestyle modifications. 

The impact of herpes zoster can be measured in a number of different ways.